Viva Biotech Holdings

HK$1.33As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1873Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (13.84%)
Div yield —
ROE 5.62%
Biotechnology
Beta (5Y) 1.28
PE TTM 16.80
TSR TTM (45.29%)
Mkt cap HK$2.772B
ROIC 4.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.30
(2.82%)
(3.23%)
Hold 10|4|11|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
26.07%
26.30%
15.78%
5.46%
Revenue¥M
265.0
263.6
260.2
255.1
(3.13%)
(1.57%)
(0.97%)
(0.87%)
Peers (US$353.6M)
Cap (US$)
PE
386.6M
36.53x
328.9M
—
352.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.552
0.527
0.422
EBIT/Intx
0.965
0.560
0.579
Own earn%
(21.64)
66.99
68.89
Sh yield%
27.24
28.52
29.57
Owners
Insiders/Inst%
8.83
45.46
Short interest%
2.60
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
6